Ligand Pharmaceuticals
LGND
#3597
Rank
C$5.04 B
Marketcap
C$256.55
Share price
-0.38%
Change (1 day)
55.60%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$0.72 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are C$0.72 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$0.15 B39.57%
2023-12-31C$0.11 B-48.93%
2022-12-31C$0.22 B-63.08%
2021-12-31C$0.60 B-27.05%
2020-12-31C$0.83 B-12.42%
2019-12-31C$0.95 B-0.31%
2018-12-31C$0.95 B200.47%
2017-12-31C$0.31 B2.33%
2016-12-31C$0.31 B-1.16%
2015-12-31C$0.31 B15.71%
2014-12-31C$0.27 B362.22%
2013-12-31C$58.65 M-24.16%
2012-12-31C$77.33 M-32.35%
2011-12-31C$0.11 B42.25%
2010-12-31C$80.37 M-44.67%
2009-12-31C$0.14 B-34.29%
2008-12-31C$0.22 B53.71%
2007-12-31C$0.14 B-58.65%
2006-12-31C$0.34 B-29.72%
2005-12-31C$0.49 B1.03%
2004-12-31C$0.48 B7.39%
2003-12-31C$0.45 B43.38%
2002-12-31C$0.31 B13.88%
2001-12-31C$0.27 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
C$111.59 B 15,190.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C$0.11 B-84.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$84.93 B 11,537.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$107.59 B 14,643.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$160.25 B 21,858.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$126.23 B 17,196.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$108.49 B 14,766.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C$19.19 B 2,530.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$157.34 B 21,460.73%๐Ÿ‡บ๐Ÿ‡ธ USA